The global Diabetic Retinopathy market size is expected to be worth around US$ 20.08 billion by 2030, according to a new report by Vision Research Reports.
The global Diabetic Retinopathy market size was valued at US$ 7.81 billion in 2020 and is anticipated to grow at a CAGR of 8.3% during forecast period 2021 to 2030.
Growth Factors
Rising prevalence of diabetes, growing geriatric population, and increasing prevalence of blindness due to diabetes are among the key factors anticipated to bolster market growth over the forecast period.
Diabetes is amongst the leading cause of blindness in people. Blindness is caused due to leaking or rupturing of retinal blood vessels, which may be permanent or temporary in nature depending on the disease-stage. According to the Department of Assistive and Rehabilitative Services (DARS), Texas, around 78.0% cases of diabetic retinopathy were reported in 2013 that may eventually lead to loss of vision. In addition, as per the Royal National Institute of Blind People (RNIB), diabetic retinopathy was amongst the leading causes of blindness in UK in 2017. Rising patient awareness levels and increasing healthcare expenditure are also among the factors which are likely to propel market growth.
Moreover, the increasing geriatric population in both developed and developing nations is expected to propel the diabetic retinopathy market over the forecast period. According to the Population Reference Bureau report titled "Aging in the United States”, the number of people in the U.S., aged 65 years and over were projected to increase from around 46 million in 2016 to over 98 million by 2060.
Report Highlights
On the basis of type, the segments are non-proliferative and proliferative diabetic retinopathy. Non-proliferative diabetic retinopathy (NPDR) dominated the overall market in 2016 owing to presence of large number of patients within the bracket of less than 10 years of diabetic history. Non-proliferative diabetic retinopathy, also called background retinopathy, is the most common diabetic eye condition and is also the leading cause of adult blindness.
Non-proliferative retinopathy typically changes from mild to moderate and then leads to severe conditions. Increased prevalence of diabetes and non-compliant retinal screening in diabetic patients are anticipated to boost the growth of the non-proliferative diabetic retinopathy market. Further, the use of drugs is increasing to cure moderate proliferation with no additional complication has contributed to revenue generation.
Proliferative diabetic retinopathy is the most advanced stage of this condition, in which fragile blood vessels leak blood into the eye resulting in blurred vision. Diabetic retinopathy can be diagnosed through comprehensive eye exams such as visual acuity test, dilated eye exam, and tonometry. Proliferative retinopathy is generally treated by laser surgery, which helps in shrinking the fragile blood vessels. Proliferative DR is anticipated to grow with the highest CAGR over the forecast period. This growth is seen due to rising target population, and geriatric population reaching the proliferative stage of retinopathy.
On the basis of management, the market is segmented into four categories namely-anti-VEGF treatment, laser surgery, intraocular steroid injection, and vitrectomy. The anti-VEGF segment dominated the market in 2016 owing to high applicability of these drugs in treatment of early diagnosis and mild to moderate cases of non-proliferative DR treatment, better treatment, and faster recovery. The major anti-VEGF agents currently used include Eylea, Avastin, Lucentis, and Macugen. The increasing usage of Lucentis due to favorable outcomes further propels the growth of the segment worldwide.
Laser photocoagulation is a highly effective treatment for diabetic retinopathy patients, therefore, this segment is expected to be the fastest-growing by 2025. Laser surgery can be done by two methods namely, scatter photocoagulation and focal laser surgery. Scatter photocoagulation is prominently used to manage proliferative DR, whereas focal is used for photographic examination prior to the surgery to identify the leakage areas around the macula.
The anticipated rise in the number of proliferative diabetic retinopathy cases during the forecast period is expected to boost the market share of the segment. Technological advancement and availability of upgraded products and equipment are further expected to boost the segmental growth.
North America region accounted for the largest share owing to the supportive reimbursement policies, and increasing prevalence of diabetes. High market penetration of Avastin, Eylea, and Lucentis which are anti-VEGF drugs, is one of the major factors contributing to the large regional share. Moreover, the market is driven by the presence of high healthcare expenditure, rising patient awareness levels, and sophisticated healthcare infrastructure.
Europe commanded the second-largest share in the diabetic retinopathy market in 2016. The expanding healthcare infrastructure along with favorable reimbursement framework in the developed European countries is expected to propel market growth during the forecast period. In addition, presence of high unmet medical needs in the emerging Eastern European markets coupled with rapidly improving healthcare infrastructure in the region is expected to fuel growth.
The emerging nations such as Japan and China in Asia Pacific are anticipated to witness lucrative growth during the forecast period owing to rising disposable income, increasing geriatric population, expanding research funding for diabetes, innovation in diagnostics, and large target patient pool.
China’s market is expected to witness rapid growth over the forecast period. Japan is the largest market in the Asia Pacific region mainly on account of the presence of high healthcare expenditure and rising disposable income. Moreover, growing usage of Lucentis is expected to drive market growth in this region.
Key Players
Novartis AG, Bayer Healthcare, Regeneron Pharmaceuticals Inc., ThromboGenics, Actavis Plc, Sirnaomics, Genentech, Alimera Sciences, Glycadia Pharmaceuticals, Ampio Pharmaceuticals, Kowa Group, and BCN Peptides.
Market Segmentation
Type Outlook
Proliferative diabetic retinopathy
Non-proliferative diabetic retinopathy
Management Outlook
Anti-VEGF
Intraocular steroid injection
Laser surgery
Vitrectomy
Regional Outlook
North America
The U.S.
Canada
Europe
Germany
UK
Asia Pacific
Japan
China
Latin America
Brazil
Middle East and Africa (MEA)
South Africa
The Diabetic Retinopathy market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Diabetic Retinopathy market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Diabetic Retinopathy market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diabetic Retinopathy market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Diabetic Retinopathy market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Diabetic Retinopathy capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Diabetic Retinopathy by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Diabetic Retinopathy market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Diabetic Retinopathy market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Diabetic Retinopathy market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Diabetic Retinopathy industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Diabetic Retinopathy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Diabetic Retinopathy market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Diabetic Retinopathy market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Diabetic Retinopathy market. These factors have benefited the growth of the global market for Diabetic Retinopathy. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Diabetic Retinopathy. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Diabetic Retinopathy are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers